In the United States, cost effectiveness in health policy debates remains a taboo subject. In fact, United States regulatory agencies are FORBIDDEN to consider cost or fund any cost-effectiveness research! Why all the fear in discussing the subject, and what are the implications in refusing to consider cost effectiveness? Read more here. (Source: George Bates, The New York Times, 12/15/14)
You are here: / / Can The United States Overcome The Taboo Of Cost-Effectiveness?